Related
Menu

gm 3 lactone

Immunogenic synthetic glycoconjugate for the immunotherapy of melanoma
managed by Office for the Valorization of Biomedical and Pharmaceutical Research (UVaR)
TRL: 4
Availability: other
Status: US Patent
Life sciences, Medicine
Details

EU-Japan Centre's News

More
EC tender opportunity : study on production & use of advanced materials
On 19 September 2024, the European Commission announced plans for a study on the production and use…
The Centre's October 2024 newsletter is out !
The Centre quarterly newsletter, October 2024 issue, is out! In this issue: Call for applicants…
Weekly Japanese Industry and Policy News: 02 - 08 Nov 2024
The EU Japan Centre is releasing a weekly press review covering Japan's economic and policy matters…

Events

More
Online and in Japan
11/11/2024 - 15/11/2024
Get ready for Japan - Oct / Nov
Join the “Get Ready for Japan” programme and expand your business operations in Japan!  21-25 Oct 2024, → 1st phase online 11-15 Nov 2024, → 2nd phase in Japan  PROGRAMME OBJECTIVES “Get Ready…
13/11/2024 - 15/11/2024
Matchmaking event at the Kawasaki International Eco-Tech Fair 2024
Join our matchmaking event and meet Japanese companies at the Kawasaki International Eco-Tech Fair 2024 in Kawasaki. The deadline to apply has been extended to 8 October 2024 at midnight (Tokyo time…

Library

Interested in being updated as to the helpdesk's activities?

By subscribing to the Newsletter, you will get constant updates about:

  • available technologies
  • recent changes in IP law
  • webinars and seminars
  • articles and presentations
Subscribe
Helpdesk links

EU-Japan Centre for Industrial Cooperation

Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.

 

The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026

Copyright © 2024 EU-Japan Centre